UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008554
Receipt number R000010055
Scientific Title The Pharmacokinetical Study of the milk in travenous cyclophosphamide therapy.
Date of disclosure of the study information 2012/07/27
Last modified on 2013/01/29 10:31:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Pharmacokinetical Study of the milk in travenous cyclophosphamide therapy.

Acronym

The Pharmacokinetical Study of the milk in travenous cyclophosphamide therapy.

Scientific Title

The Pharmacokinetical Study of the milk in travenous cyclophosphamide therapy.

Scientific Title:Acronym

The Pharmacokinetical Study of the milk in travenous cyclophosphamide therapy.

Region

Japan


Condition

Condition

SLE (systemic lupus erythematosus)

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

examine the drug concentration of milk in travenous cyclophosphamide therapy.

Basic objectives2

Pharmacokinetics

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Concentration measurement and assessment of the breast-fed child's safety.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

measuring instrument

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

41 years-old <=

Age-upper limit

41 years-old >=

Gender

Female

Key inclusion criteria

SLE
travenous cyclophosphsmide therapy
breast feeding

Key exclusion criteria

nothing

Target sample size

1


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Fumiki Hirahara

Organization

Yokohama City University School of Medicine

Division name

obstetrics and gynecology

Zip code


Address

3-9, Fukuura, Kanazawa-ku, Yokohama

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Yokohama City University School of Medicine

Division name

obstetrics and gynecology

Zip code


Address


TEL

045-787-2800

Homepage URL


Email



Sponsor or person

Institute

Yokohama City University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

not yet

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 07 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2012 Year 07 Month 06 Day

Date of IRB


Anticipated trial start date

2012 Year 07 Month 27 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 07 Month 27 Day

Last modified on

2013 Year 01 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010055


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name